506 results on '"Zaza, Antonio"'
Search Results
2. Insights from an electro-mechanical heart failure cell model: Role of SERCA enhancement on arrhythmogenesis and myocyte contraction
3. Kinematics but not kinetics alterations to single-leg drop jump movements following a subject-tailored fatiguing protocol suggest an increased risk of ACL injury.
4. The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function
5. Deranged sodium to sudden death
6. Early consequences of the phospholamban mutation PLN‐R14del+/− in a transgenic mouse model.
7. Selective SERCA2a activator as a candidate for chronic heart failure therapy
8. Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome
9. Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2
10. Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches
11. Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment
12. 25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies
13. Anatomy and physiology of the sinus node
14. Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling
15. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
16. Early consequences of the phospholamban mutation PLN-R14del+/-in a transgenic mouse model
17. Batch Action PoTential Analyser (BAPTA): an open source tool for automated high throughput analysis of cardiac action potentials
18. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
19. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
20. Biopacemaking: Clinically Attractive, Scientifically a Challenge
21. Exploring the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy
22. Combined action potential- and dynamic-clamp for accurate computational modelling of the cardiac IKr current
23. Unraveling the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy
24. Characterization of the PLN-R14Del mutation in hiPSC-derived cardiomyocytes
25. Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function
26. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes
27. Late sodium current (INaL) in pancreatic β-cells
28. Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
29. Late sodium current and intracellular ionic homeostasis in acute ischemia
30. Mobile Anchors
31. Insights from an Electro-Mechanical Heart Failure Cell Model: Role of SERCA Enhancement on Arrhythmogenesis and Myocyte Contraction
32. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
33. Tissue-specificty Of Mitochondrial Adaptations After 4 Weeks Of Normobaric Hypoxia In Rats: 2038 Board #190 June 2, 3: 30 PM - 5: 00 PM
34. Electrophysiology meets geometry
35. Straightforward synthesis of novel Akt inhibitors based on a glucose scaffold
36. Edward Carmeliet (1930–2021)—channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiology
37. SERCA2a gain of function in patient-derived R14Del hiPSC-CMs
38. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)
39. IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp
40. Modulation of sympathetic activity and heart rate variability by ivabradine
41. Opportunities and challenges of current electrophysiology research: a plea to establish ‘translational electrophysiology’ curricula
42. Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains
43. The Late Na+ Current - Origin and Pathophysiological Relevance
44. Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function
45. ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research
46. MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
47. Caffeine-induced Ca2+ signaling as an index of cardiac progenitor cells differentiation
48. Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations
49. Repolarization instability and arrhythmia susceptibility upon IKr block in isolated and 2D-monolayers of hiPSC-CMs
50. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.